Tuesday, July 28, 2015

GSK diabetes drug Avandia harms heart The New York Times reports

The controversial diabetes drug Avandia causes about 500 people to have preventable heart attacks each month, The New York Times reported. And if another drug were used by all the patients taking Avandia, an additional 300 people a month wouldn't develop heart failure, internal government documents obtained by the newspaper said.

GSK diabetes drug Avandia harms heart The New York Times reports

0 comments

The controversial diabetes drug Avandia causes about 500 people to have preventable heart attacks each month, The New York Times reported. And if another drug were used by all the patients taking Avandia, an additional 300 people a month wouldn't develop heart failure, internal government documents obtained by the newspaper said.

The Times story said that the U.S. Food and Drug Administration linked Avandia to 304 deaths in the last three months of 2009. Avandia is made by GlaxoSmithKline. It is used to treat type 2 diabetes.

A bipartisan Senate investigation led by Sens. Max Baucus (D., Mont.) and Charles Grassley (R., Iowa) is expected to release its report on Avandia on Monday. That report – also obtained by The Times - criticizes GlaxoSmithKline for failing to warn patients sooner that Avandia was potentially deadly.

Check out the full story here.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog

Check Up covers regional health news and a wide array of healthcare topics from pharmaceutical happenings to patient safety. Read about some of our bloggers here.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
letter icon Newsletter